🔎 Trials Near Me

Gara Jalqabaatti › Diffuse Large B-Cell Lymphoma › Indiana

Qorannoo klinikaalii Diffuse Large B-Cell Lymphoma Indiana keessatti

Qorannoo 9 Diffuse Large B-Cell Lymphoma f Indiana keessatti hirmaatuu jiru.

Magaalota Indiana keessatti

Takkalaa qorannoo (Ingiliffa)

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

  • Fort Wayne Medical Oncology and Hematology, Fort Wayne
  • IU Simon Comprehensive Cancer Center, Indianapolis
  • Indiana Blood and Marrow Transplantation, Indianapolis
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06500273

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

  • Northwest Cancer Center - Crown Point, Crown Point
  • Northwest Oncology LLC, Dyer
  • Saint Mary Medical Center, Hobart
  • fi 4 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06649812

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
  • St Vincent Ascension at Peyton Manning Childrens Hospital, Indianapolis
  • Investigative Clinical Research of Indiana, Noblesville
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06091865

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Indiana Blood and Marrow Transplantation, Indianapolis
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05826535

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ado-2026 · NCT05852717

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

  • Northwest Cancer Center - Main Campus, Crown Point
  • Northwest Oncology LLC, Dyer
  • Northwest Cancer Center - Hobart, Hobart
  • fi 5 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Onk-2025 · NCT05890352

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  • Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Elb-2023 · NCT04920617

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

  • Goshen Center for Cancer Care, Goshen
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2022 · NCT04502394

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.